Jaillon P

References (4)

Title : Fully automated determination of eserine N-oxide in human plasma using on-line solid-phase extraction with liquid chromatography coupled with electrospray ionization tandem mass spectrometry - Pruvost_2000_J.Mass.Spectrom_35_625
Author(s) : Pruvost A , Ragueneau I , Ferry A , Jaillon P , Grognet J , Benech H
Ref : J Mass Spectrom , 35 :625 , 2000
Abstract : Pruvost_2000_J.Mass.Spectrom_35_625
ESTHER : Pruvost_2000_J.Mass.Spectrom_35_625
PubMedSearch : Pruvost_2000_J.Mass.Spectrom_35_625
PubMedID: 10800052

Title : Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man - Becquemont_1998_Pharmacogenet_8_101
Author(s) : Becquemont L , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P , Beaune P
Ref : Pharmacogenetics , 8 :101 , 1998
Abstract : Becquemont_1998_Pharmacogenet_8_101
ESTHER : Becquemont_1998_Pharmacogenet_8_101
PubMedSearch : Becquemont_1998_Pharmacogenet_8_101
PubMedID: 10022747

Title : Glutathione S-transferase theta genetic polymorphism might influence tacrine hepatotoxicity in Alzheimer's patients -
Author(s) : Becquemont L , Lecoeur S , Simon T , Beaune P , Funck-Brentano C , Jaillon P
Ref : Pharmacogenetics , 7 :251 , 1997
PubMedID: 9241666

Title : Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans - Becquemont_1997_Clin.Pharmacol.Ther_61_619
Author(s) : Becquemont L , Ragueneau I , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P
Ref : Clinical Pharmacology & Therapeutics , 61 :619 , 1997
Abstract : Becquemont_1997_Clin.Pharmacol.Ther_61_619
ESTHER : Becquemont_1997_Clin.Pharmacol.Ther_61_619
PubMedSearch : Becquemont_1997_Clin.Pharmacol.Ther_61_619
PubMedID: 9209244